Oxford Asset Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Oxford Asset Management’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-13,179	Closed	-$178K	–	2235
2018 Q4	$178K	Buy	+13,179	New	+$147K	﹤0.01%	1566
2015 Q3	–	Sell	-128,247	Closed	-$2.5M	–	831
2015 Q2	$2.5M	Sell	128,247 -40,409	-24%	-$715K	0.07%	313
2015 Q1	$2.96M	Buy	168,656 +80,971	+92%	+$1.36M	0.08%	285
2014 Q4	$1.4M	Buy	+87,685	New	+$1.17M	0.03%	430

Other funds holding OSIR

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CCM

Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Oxford Asset Management's OSIR Position: Q1 2019 in Review

Oxford Asset Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2019, closing a stake of 13,179 shares — an estimated $178K sold.

Oxford Asset Management first reported a position in OSIR in Q4 2014 and held it in 4 quarters. The position peaked at $2.96M in Q1 2015. 57 funds tracked by Wall St. Rank hold OSIR as of Q1 2019.

Oxford Asset Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Oxford Asset Management sold 13,179 Osiris Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $178K.
Oxford Asset Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2014 and held it in 4 quarters.
Oxford Asset Management's Osiris Therapeutics, Inc. Common Stock position peaked at $2.96M in Q1 2015.
57 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Oxford Asset Management's 13F filing for Q1 2019, filed 15 May 2019.